Literature DB >> 34651284

The effectiveness of Glasgow-Blatchford Score in early risk assessment of hemodialysis patients.

Dilay Satılmış1, Burcu Genc Yavuz2, Oya Güven3, Ramazan Güven4, Başar Cander5.   

Abstract

In the emergency departments (ED), the incidence of admission is increasing gradually due to gastrointestinal system (GIS) complications of hemodialysis (HD) patients. With this increasing number of patients, there are many classification systems developed in early risk assessment before endoscopy. In this study, we aimed to evaluate the Glasgow-Blatchford Score's (GBS) effectiveness in HD patients with suspected GIS hemorrhage in the ED.The files of 169 patients who received HD treatment were retrospectively reviewed. 64 patients who were examined and treated for reasons other than GIS hemorrhage in the ED were excluded, and the files of a total of 105 were analyzed retrospectively. The demographic characteristics and laboratory values of the patients were recorded from the patient files. When the patients were evaluated according to GBS parameters, a significant difference was found between the two groups in terms of pulse pressure, systolic blood pressure, hemoglobin value, melena, and accompanying comorbid diseases (p < 0.05). Of the 16 patients who presented to the ED due to syncope, 2 were in the GIS hemorrhage (+) group, and 14 patients were in the control group. In this study, we aimed to show that the increase in the number of admissions in the ED due to complications secondary to HD treatment and the accompanying serious changes in laboratory parameters may cause misleading results in patients with suspected GIS hemorrhage, and it is necessary to plan comprehensive and multi-center studies on new alternative scoring systems to GBS in specific patient groups such as HD patients.
© 2021. Società Italiana di Medicina Interna (SIMI).

Entities:  

Keywords:  End-stage renal disease; Gastrointestinal system; Glasgow-Blatchford Score; Hemodialysis; Hemorrhage

Mesh:

Year:  2021        PMID: 34651284     DOI: 10.1007/s11739-021-02869-8

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  9 in total

1.  Clinical triage decision vs risk scores in predicting the need for endotherapy in upper gastrointestinal bleeding.

Authors:  Farees T Farooq; Michael H Lee; Ananya Das; Rahul Dixit; Richard C K Wong
Journal:  Am J Emerg Med       Date:  2010-12-24       Impact factor: 2.469

Review 2.  Bleeding in patients with renal insufficiency: a practical guide to clinical management.

Authors:  Azim S Gangji; Avtar S Sohal; Darin Treleaven; Mark A Crowther
Journal:  Thromb Res       Date:  2005-06-22       Impact factor: 3.944

Review 3.  Upper gastrointestinal bleeding risk scores: Who, when and why?

Authors:  Sara Monteiro; Tiago Cúrdia Gonçalves; Joana Magalhães; José Cotter
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

4.  Emergency department risk stratification in upper gastrointestinal bleeding.

Authors:  Huma Ali; Eddy Lang; Alan Barkan
Journal:  CJEM       Date:  2012-01       Impact factor: 2.410

5.  A risk score to predict need for treatment for upper-gastrointestinal haemorrhage.

Authors:  O Blatchford; W R Murray; M Blatchford
Journal:  Lancet       Date:  2000-10-14       Impact factor: 79.321

6.  Effects of cutaneous aspirin on the human stomach and duodenum.

Authors:  B Cryer; D Kliewer; H Sie; L McAllister; M Feldman
Journal:  Proc Assoc Am Physicians       Date:  1999 Sep-Oct

7.  Etiology of upper gastrointestinal bleeding in Jordanian patients: A prospective study.

Authors:  M M Shennak
Journal:  Ann Saudi Med       Date:  1995-01       Impact factor: 1.526

8.  Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding.

Authors:  Alan Barkun; Marc Bardou; John K Marshall
Journal:  Ann Intern Med       Date:  2003-11-18       Impact factor: 25.391

9.  Hemostatic Abnormalities in Severe Renal Failure: Do They Bark or Bite?

Authors:  A Mohapatra; A T Valson; B Gopal; S Singh; S C Nair; A Viswabandya; S Varughese; V Tamilarasi; G T John
Journal:  Indian J Nephrol       Date:  2018 Mar-Apr
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.